IGM Biosciences, Inc.
IGMS
$1.28
$0.064.92%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 39.62% | 0.90% | 25.64% | 16.01% | -15.44% |
| Total Depreciation and Amortization | 7.89% | 2.12% | 4.74% | 30.77% | 14.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -43.47% | 15.26% | -39.01% | -29.18% | -23.07% |
| Change in Net Operating Assets | -961.90% | -24.04% | 84.69% | 39.60% | 61.57% |
| Cash from Operations | 27.47% | 4.33% | 29.62% | 16.82% | -26.81% |
| Capital Expenditure | 40.47% | 58.09% | 68.98% | 36.91% | 46.27% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 242.39% | -36.94% | 1,165.75% | -84.90% | 17.81% |
| Cash from Investing | 222.49% | -33.57% | 487.73% | -87.61% | 21.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.48% | -97.31% | -99.08% | 156.00% | -16.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.48% | -97.31% | -99.12% | 102.67% | -16.60% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 73.67% | -200.54% | -216.28% | -277.83% | -10.88% |